Refine
Year of publication
Document Type
- Article (525) (remove)
Has Fulltext
- yes (525)
Is part of the Bibliography
- no (525)
Keywords
- Milchwirtschaft (36)
- Molkerei (27)
- Euterentzündung (23)
- Logistik (20)
- Student (11)
- Supervision (11)
- Knowledge (10)
- Mumbai (10)
- Wissen (10)
- Bibliothek (9)
Ausgangspunkt des Forschungsvorhabens SchuLae bildet die angestrebte flächendeckende Einführung institutioneller Schutzkonzepte in pädagogischen Kontexten. Im Zuge eines durch Schutzkonzepte in Gang gesetzten Organisationsentwicklungsprozesses sollen Orte des Aufwachsens für Kinder und Jugendliche zu Schutz- und Kompetenzorten werden. Ob Schutzkonzepte tatsächlich zu einem Rückgang von Viktimisierungserfahrungen und einer erhöhten Bereitschaft zur Hilfe(suche) führen, wurde bislang nicht empirisch erfasst. Der vom Bundesministerium für Bildung und Forschung (BMBF) geförderte Verbund „SchuLae – Entwicklung und Wirkung von Schutzkonzepten in Schulen im Längsschnitt“ des Deutschen Jugendinstituts und der Hochschule Hannover untersucht daher die Wirksamkeit schulischer Schutzkonzepte sowohl quantitativ als auch qualitativ im Längsschnitt und fokussiert dabei die Perspektiven von Schüler*innen.
Das PROFINET Protokoll wurde in der aktuellen Version um Security-Funktionen erweitert. Damit können für PROFINET flexible Netzwerkarchitekturen unter Berücksichtigung von OT-Security Anforderungen entworfen werden, die durch die bisher erforderliche Netzwerksegmentierung nicht möglich waren. Neben den Herstellern der Protokollstacks sind nachfolgend auch die Komponentenhersteller gefordert, eine sichere Implementierung in ihren Geräten umzusetzen. Die erforderlichen Maßnahmen gehen dabei über die Nutzung eines sicheren Protokollstacks hinaus. Der Beitrag zeigt am Beispiel eines Ethernet-APL Messumformers mit PROFINET-Kommunikation die künftig von PROFINET-Geräteherstellern zu berücksichtigenden technischen und organisatorischen Rahmenbedingungen.
Der Aufsatz erläutert anschaulich, wie der Transport der elektrischen Energie vom Erzeuger zum Verbraucher im Detail erfolgt. Die Rechnung mit Hilfe grundlegender Beziehungen aus den Grundlagen der Elektrotechnik und dem Poynting-Vektor ermöglicht es, den physikalisch realen Transport der Energie räumlich quantitativ nachzuvollziehen und zu verstehen. An vereinfachten Beispielen wird gezeigt, wie die Energie über zwei Sammelschienen zu den Verbrauchern und insbesondere in die Verbraucher hinein gelangt. Bei den Verbrauchern handelt es sich exemplarisch um einen Widerstand, einen Kondensator, eine Spule und schließlich einen bewegten Leiter im magnetischen Feld als einfachste Form eines Gleichstrommotors. Es wird dargestellt, dass die Energie keinesfalls in den Zuleitungen transportiert wird, sondern durch den umgebenden Raum.
Ob Veränderungsprojekte in Organisationen erfolgreich sind, hängt entscheidend davon ab, ob und wie die entwickelten Lösungen von den betroffenen Mitarbeitern angenommen und umgesetzt werden. Es sind nicht wirklich die Unternehmen, die sich verändern: Der Wandel muss in und mit den Menschen in den Unternehmen stattfinden. Dies kann aber nur durch Überzeugung gelingen und zwar im wesentlichen herbeigeführt durch Kommunikation. Von Bedeutung sind jedoch nicht so sehr die Massenmedien wie die Mitarbeiterzeitschrift, Broschüren oder das Intranet. Mit ihnen wird der Veränderungsprozess angestoßen und laufend unterstützt. Entscheidend für seinen Erfolg oder Misserfolg ist jedoch die geplante und organisierte persönliche Kommunikation vor allem zwischen dem Management und den Mitarbeitern. Führungskräfte müssen sich ihrer Rolle als Meinungsführer und Meinungsbildner bewusst werden und entsprechend handeln. Dazu gehört auch das Kommunikationsmanagement und der phasengerechte Einsatz von Kommunikationsinstrumenten zum gewünschten Zweck.
Background
The business of clinical research has changed in the past two decades, shifting from industrialised Western countries to so-called emerging markets such as Eastern Europe, Latin America and Africa. An appraisal of the trends could identify associated factors that may have implications for the local populations and their endemic diseases.
Objectives
To identify potential reasons why emerging countries have become attractive places for international sponsors to conduct their clinical trials.
Methods
Using ClinicalTrials.gov, the Pan African Clinical Trials Registry, the National Health Research Database and the Nigeria Clinical Trials Registry, trend data on clinical research development were determined for two emerging African markets, Nigeria and South Africa (SA), from 2010 to 2018. Also, health data on the two countries from the fact sheets of health statistics of the World Health Organization were compared, as well as regulatory and ethical conditions. Available data were analysed using descriptive statistics and trend analysis.
Results
The impact of globalisation is evident from the upward trend in clinical trials in SA before 2010, and the clear downward trend thereafter. One reason for this change could be the alignment of SA’s regulatory and ethical frameworks with the Western world. In contrast,
the upward trend is only just beginning in Nigeria, with the introduction of ethical/regulatory frameworks, and supportive institutions making the business of clinical research more attractive on an international level. Although the number of international and local sponsors increased in Nigeria from 2010 to 2018, only the latter increased in SA, with the former decreasing over the same period. Overall, there is a mismatch between country-specific diseases and the drugs being tested, to the extent that leprosy, which is endemic in Nigeria, and tuberculosis in SA were not in the list of top 10 study areas in either country.
Conclusions
The globalisation trend is evident in the clinical trials business, but cannot be generalised to all emerging countries. Timing and intensity vary from country to country relative to factors that advance the existing profit-orientated business models of the sponsors. Furthermore, various diseases have been localised, which entails a diversely increasing need for research.
Objectives:
The aim was to identify theoretically expected as well as actually reported benefits from drug development and the importance of individual patient benefits compared to the collective benefits to society in general.
Background:
Ethical guidelines require that clinical research involving humans offer the potential for benefit. A number of characteristics can be applied to define research benefit. Often benefit is categorized as being either direct or indirect. Indirect benefits can involve collective benefits for society rather than any benefits to the trial patient or subject. The purpose of this review was to examine which potential individual and societal benefits were mentioned as being expected in publications from government experts and which were mentioned in publications describing completed drug development trial results.
Methods:
Literature on research benefit was first identified by searching the PubMed database using several combinations of the key words benefit and clinical research. The search was limited to articles published in English. A Google search with the same combinations of key words but without any language limitation was then performed. Additionally, the reference lists of promising articles were screened for further thematically related articles. Finally, a narrative review was performed of relevant English- and German-language articles published between 1996 and 2016 to identify which of several potential benefits were either theoretically expected or which were mentioned in publications on clinical drug development trial results.
Results:
The principal benefits from drug development discussed included 2 main types of benefit, namely individual benefits for the patients and collective benefits for society. Twenty-one of an overall total of 26 articles discussing theoretically expected benefits focused on individual patient benefits, whereas 17 out of 26 articles mentioned collective benefits to society. In these publications, the most commonly mentioned theoretically expected individual patient benefit was the chance to receive up-to-date care (38.1%). A general increase in knowledge about health care, treatments, or drugs (70.6%) was the most commonly mentioned theoretically expected benefit for society. In contrast, all 13 publications reporting actual benefits of clinical drug development trials focused on personal benefits and only 1 of these publications also mentioned a societal benefit. The most commonly mentioned individual benefit was an increased quality of life (53.9%), whereas the only mentioned collective benefit to society was a general gain of knowledge (100.0%).
Conclusions:
Both theoretically expected and actually reported benefits in the majority of the included publications emphasized the importance of individual patient benefits from drug development rather than the collective benefits to society in general. The authors of these publications emphasized the right of each individual patient or subject to look for and expect some personal benefit from participating in a clinical trial rather than considering societal benefit as a top priority. From an ethical point of view, the benefits each individual patient receives from his or her participation in a clinical trial might also be seen as a societal benefit, especially when the drug or device tested, if approved for marketing, would eventually be made available for other similar patients from the country in which the clinical trial was conducted.
Objectives
Quality of care largely depends on successful teamwork, which in turn needs effective communication between health professionals. To communicate successfully in a team, health professionals need to strive for the same goals. However, it has been left largely unaddressed which goals professionals consider to be important. In this study, we aim to identify these goals and analyse whether differences between (1) personal and organisational goals, (2) different professions and (3) hierarchical levels exist in neonatal intensive care units (NICUs).
Design
Goals were identified based on a literature review and a workshop with health professionals and tested in a pilot study. Subsequently, in the main study, a cross-sectional employee survey was undertaken.
Setting and participants
1489 nurses and 537 physicians from 66 German NICUs completed the
questionnaire regarding personal and organisational goal importance between May and July 2013. Answers were given based on a 7-point Likert scale varying between none and exceptionally high importance.
Results
Results show that the goals can be subdivided into three main goal dimensions: patients, parents and staff. Furthermore, our results reveal significant differences between different professions and different hierarchical level: physicians rated patient goals with a
mean (95% CI) importance of 6.37 (3.32 to 6.43), which is significantly higher than nurses with a mean (95% CI) importance of 6.15 (6.12 to 6.19) (p<0.01). Otherwise, nurses classified parental goals as more important (p<0.01). Furthermore, professionals in leading positions rate patient goals significantly higher than professionals that are not in leading positions (6.36 (3.28 to 6.44) vs 6.19 (6.15 to 6.22), p<0.01).
Conclusions
Different employee goals need to be considered in decision-making
processes to enhance employee motivation and the effectiveness of teamwork.
Wearable sensors in healthcare and sensor-enhanced health information systems: all our tomorrows?
(2012)
Wearable sensor systems which allow for remote or self-monitoring of health-related parameters are regarded as one means to alleviate the consequences of demographic change. This paper aims to summarize current research in wearable sensors as well as in sensor-enhanced health information systems. Wearable sensor technologies are already advanced in terms of their technical capabilities and are frequently used for cardio-vascular monitoring. Epidemiologic predictions suggest that neuro-psychiatric diseases will have a growing impact on our health systems and thus should be addressed more intensively. Two current project examples demonstrate the benefit of wearable sensor technologies: long-term, objective measurement under daily-life, unsupervised conditions. Finally, up-to-date approaches for the implementation of sensor-enhanced health information systems are outlined. Wearable sensors are an integral part of future pervasive, ubiquitous and person-centered health
care delivery. Future challenges include their integration into sensor-enhanced health information systems and sound evaluation studies involving measures of workload reduction and costs.
Der folgende Beitrag fasst die jüngsten Ergebnisse einer Studierendenbefragung zusammen, die im Rahmen des BMBF-geförderten Forschungsprojekts „ZEITLast: Lehrzeit und Lernzeit: Studierbarkeit der BA-/BSc- und MA-/MSc- Studiengänge als Adaption von Lehrorganisation und Zeitmanagement unter Berücksichtigung von Fächerkultur und Neuen Technologien“ im Wintersemester 2010/2011 in den beiden Studiengängen „Informationsmanagement und Informationstechnologie“ und „Polyvalenter 2-Fächer-Bachelor-Studiengang mit Lehramtsoption“ an der Stiftung Universität Hildesheim durchgeführt wurde. Dieser Befragung ging in beiden Studiengängen eine Zeitbudgeterhebung voraus. Zentrale Ergebnisse werden im Folgenden vorgestellt und im Weiteren exemplarisch in den wissenschaftlichen Diskurs eingebunden. Deutlich wird, dass das Gefühl von Belastung nicht auf die reine Zeitinvestition in das Studium zurückzuführen ist, sondern auch in engem Zusammenhang mit der vorherrschenden Lehrorganisation an der Hochschule und den eigenen studentischen Kompetenzen zu sehen ist.
Ausfall- und Ausfallfolgekosten sowie Wiederanlauf- und Zusatzlaufkosten zwingen auch nach betriebswirtschaftlichen Gesichtspunkten die Unternehmen, die Bedeutung und den Umfang der Instandhaltungsaktivitäten höher als bisher einzuschätzen. Der Artikel befasst sich mit der Fragen, warum die Wartung mit in das Logistik-Konzept aufgenommen werden soll.